Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;25(1):15-16.
doi: 10.18553/jmcp.2019.25.1.015.

TTR Gene Silencers for Hereditary ATTR Amyloidosis: More than ICER Recognized

John L Berk  1
Affiliations

TTR Gene Silencers for Hereditary ATTR Amyloidosis: More than ICER Recognized

John L Berk. J Manag Care Spec Pharm. 2019 Jan.

Abstract

No funding support was received for the writing of this commentary. The author ser ves as a consultant for Akcea Therapeutics, Alnylam Phar maceuticals, Corino Therapeutics, Intellia Therapeutics, and Ionis Pharmaceuticals.

PubMed Disclaimer

Conflict of interest statement

No funding support was received for the writing of this commentary. The author ser ves as a consultant for Akcea Therapeutics, Alnylam Phar maceuticals, Corino Therapeutics, Intellia Therapeutics, and Ionis Pharmaceuticals.

Similar articles

See all similar articles

Cited by

References

    1. Adams D, Gonzalez-Duarte A, O’Riordan WD, et al. . Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018;379(1):11-21. - PubMed
    1. Benson MD, Waddington-Cruz M, Berk JL, et al. . Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med. 2018;379(1):22-31. - PubMed
    1. Buxbaum JN. Oligonucleotide drugs for transthyretin amyloidosis. N Engl J Med. 2018;379(1):82-85. - PubMed
    1. Berk JL, Suhr OB, Obici L, et al. . Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. JAMA. 2013;310(24):2658-67. - PMC - PubMed
    1. Coelho T, Maia LF, Martins da Silva A, et al. . Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized controlled trial. Neurology. 2012;79(8):785-92. - PMC - PubMed

MeSH terms

Supplementary concepts